Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 317
Gene Symbol: APAF1
APAF1
0.010 Biomarker disease BEFREE Amyloid β binds procaspase-9 to inhibit assembly of Apaf-1 apoptosome and intrinsic apoptosis pathway. 24424093 2014
Entrez Id: 351
Gene Symbol: APP
APP
0.400 Biomarker disease BEFREE Amyloid β (Aβ) peptides originating from amyloid precursor protein (APP) in the endosomal-lysosomal compartments play a critical role in the development of Alzheimer's disease (AD), the most common type of senile dementia affecting the elderly. 25939386 2015
Entrez Id: 353
Gene Symbol: APRT
APRT
0.020 AlteredExpression disease BEFREE Amyloid-β suppresses AMP-activated protein kinase (AMPK) signaling and contributes to α-synuclein-induced cytotoxicity. 26515689 2016
Entrez Id: 4236
Gene Symbol: MFAP1
MFAP1
0.020 AlteredExpression disease BEFREE Amyloid-β suppresses AMP-activated protein kinase (AMPK) signaling and contributes to α-synuclein-induced cytotoxicity. 26515689 2016
Entrez Id: 114548
Gene Symbol: NLRP3
NLRP3
0.100 Biomarker disease BEFREE Amyloid β induces NLRP3 inflammasome activation in retinal pigment epithelial cells via NADPH oxidase- and mitochondria-dependent ROS production. 28004443 2017
Entrez Id: 551
Gene Symbol: AVP
AVP
0.010 GeneticVariation disease BEFREE Amyloid-assembly kinetics, transmission electron microscopy (TEM), and atomic force microscopy (AFM) show that ADH-41 wholly suppresses the aggregation of Aβ at a substoichiometric dose. 28273416 2017
Entrez Id: 353
Gene Symbol: APRT
APRT
0.020 Biomarker disease BEFREE Amyloid-β oligomers transiently inhibit AMP-activated kinase and cause metabolic defects in hippocampal neurons. 28302722 2017
Entrez Id: 4236
Gene Symbol: MFAP1
MFAP1
0.020 Biomarker disease BEFREE Amyloid-β oligomers transiently inhibit AMP-activated kinase and cause metabolic defects in hippocampal neurons. 28302722 2017
Entrez Id: 7276
Gene Symbol: TTR
TTR
0.500 Biomarker disease BEFREE Amyloid stained intensely with h-FTAA and an anti-TTR-antibody. 28434259 2017
Entrez Id: 7306
Gene Symbol: TYRP1
TYRP1
0.020 Biomarker disease BEFREE Amyloid B-protein/amyloid A4 is a peptide present in the neuritic plaques, neurofibrillary tangles and cerebrovascular deposits in patients with Alzheimer's disease and Down's syndrome (trisomy 21) and may be involved in the pathogenesis of Alzheimer's disease. 2893290 1988
Entrez Id: 120892
Gene Symbol: LRRK2
LRRK2
0.020 Biomarker disease BEFREE Amyloid is the main pathological substrate of Alzheimer's disease (AD) and has been described in leucine-rich repeat kinase 2 (LRRK2) carriers with Parkinson's disease. 29241968 2018
Entrez Id: 10058
Gene Symbol: ABCB6
ABCB6
0.040 Biomarker disease BEFREE Amyloid-beta Interactions with ABC Transporters and Resistance Modifiers. 29848690 2018
Entrez Id: 58157
Gene Symbol: NGB
NGB
0.020 Biomarker disease BEFREE Amyloid-β25-35 Upregulates Endogenous Neuroprotectant Neuroglobin via NFκB Activation in vitro. 30010125 2018
Entrez Id: 348
Gene Symbol: APOE
APOE
0.400 Biomarker disease BEFREE Amyloid-peptide β 42 Enhances the Oligomerization and Neurotoxicity of apoE4: The C-terminal Residues Leu279, Lys282 and Gln284 Modulate the Structural and Functional Properties of apoE4. 30367942 2018
Entrez Id: 351
Gene Symbol: APP
APP
0.400 Biomarker disease BEFREE Amyloid-β (Aβ) is derived from the proteolytic processing of amyloid precursor protein (APP), and the deposition of extracellular Aβ to form amyloid plaques is a pathologic hallmark of Alzheimer's disease (AD). 31373844 2019
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.100 Biomarker disease BEFREE Amyloid-PET should be prioritized over CSF biomarkers in the diagnostic workup of patients investigated for suspected AD, as it provides greater changes in diagnosis and diagnostic confidence. 31388720 2020
Entrez Id: 3918
Gene Symbol: LAMC2
LAMC2
0.100 Biomarker disease BEFREE Amyloid-PET should be prioritized over CSF biomarkers in the diagnostic workup of patients investigated for suspected AD, as it provides greater changes in diagnosis and diagnostic confidence. 31388720 2020
Entrez Id: 2670
Gene Symbol: GFAP
GFAP
0.100 Biomarker disease BEFREE Amyloid β protein (Aβ), glial fibrillary acidic protein (GFAP), endogenous ligands for TLR2, and the activation of downstream signaling of TLR2 in mouse brains were detected by immunohistochemistry and Western blots. 31509519 2019
Entrez Id: 7097
Gene Symbol: TLR2
TLR2
0.030 Biomarker disease BEFREE Amyloid β protein (Aβ), glial fibrillary acidic protein (GFAP), endogenous ligands for TLR2, and the activation of downstream signaling of TLR2 in mouse brains were detected by immunohistochemistry and Western blots. 31509519 2019
Entrez Id: 7276
Gene Symbol: TTR
TTR
0.500 Biomarker disease BEFREE Amyloid in hereditary amyloid polyneuropathy is related to prealbumin. 7018469 1981
Entrez Id: 7276
Gene Symbol: TTR
TTR
0.500 Biomarker disease BEFREE Amyloid TTR is modified in several ways. 8095018 1993
Entrez Id: 7276
Gene Symbol: TTR
TTR
0.500 GeneticVariation disease BEFREE Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis. 10071047 1999
Entrez Id: 1634
Gene Symbol: DCN
DCN
0.010 Biomarker disease BEFREE Decorin, biglycan, and collagen type I were localized immunohistochemically in human renal biopsy cases of amyloidosis (N = 18), diabetic nephropathy (N = 11), fibrillary glomerulonephritis (N = 5), immunotactoid glomerulopathy (N = 5), light-chain deposition disease (N = 4), idiopathic mesangial sclerosis (N = 4), and nephrosclerosis (N = 6), and in morphologically normal tissues obtained from tumor nephrectomies (N = 8). 10652025 2000
Entrez Id: 4210
Gene Symbol: MEFV
MEFV
0.100 GeneticVariation disease BEFREE MEFV mutations in multiplex families with familial Mediterranean fever: is a particular genotype necessary for amyloidosis? 10905662 2000
Entrez Id: 567
Gene Symbol: B2M
B2M
0.100 Biomarker disease BEFREE beta(2)-Microglobulin (beta(2)m) amyloidosis is a destructive articular disease that affects patients on dialysis. 11318968 2001